Matthew Ciorba
Expertise in
11
conditions

Dr. Matthew Ciorba

Gastroenterology
Office
4921 Parkview Pl Fl 8, 
Saint Louis, MO 
Expertise in
11
conditions
Office
4921 Parkview Pl Fl 8, 
Saint Louis, MO 

Overview

Matthew Ciorba is a Gastroenterologist practicing medicine in Saint Louis, Missouri.

Dr. Ciorba is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Viral Gastroenteritis, Crohn's Disease, Colitis, Small Bowel Resection, and Colonoscopy.

He is actively involved in clinical research, co-authoring 129 peer reviewed articles and participating in 6 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in MO

Hospital Affiliations

Barnes-Jewish West County Hospital
Barnes Jewish Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Office
4921 Parkview Pl Fl 8, Saint Louis, MO 63110
Other Locations
Barnes-Jewish Hospital
1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase I Open Label Study of the Efficacy and Safety of Tudca in Ulcerative Colitis
A Phase I Open Label Study of the Efficacy and Safety of Tudca in Ulcerative Colitis
Enrollment Status: Completed
Publish Date: March 10, 2026
Intervention Type: Drug
Study Drug: Tauroursoursodeoxycholic acid
Study Phase: Phase 1
Safety and Efficacy Study of Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Safety and Efficacy Study of Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Drug, Radiation
Study Drugs: Epacadostat, Bevacizumab
Study Phase: Phase 2
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

129 Total Publications

Novel mouse models for perianal fistulizing Crohn's disease reveal therapeutic value of interferon-γ antagonists.
Novel mouse models for perianal fistulizing Crohn's disease reveal therapeutic value of interferon-γ antagonists.
Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026
Similar Doctors
Expertise in
22
conditions
Dr. Chandra Gyawali
Gastroenterology
Expertise in
22
conditions
Dr. Chandra Gyawali
Gastroenterology
Referral may be required

Washington University

660 S Euclid Ave, 
Saint Louis, MO 
 (0.1 miles away)
314-747-2913
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Chandra Gyawali is a Gastroenterologist practicing medicine in Saint Louis, Missouri. Dr. Gyawali is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Hiatal Hernia, Achalasia, Endoscopy, and Gastric Bypass.

Expertise in
36
conditions
Dr. Vladimir Kushnir
Gastroenterology
Expertise in
36
conditions
Dr. Vladimir Kushnir
Gastroenterology
Referral may be required

Washington University

660 S Euclid Ave, 
Saint Louis, MO 
 (0.1 miles away)
314-747-2066
Languages Spoken:
English
See accepted insurances

Vladimir Kushnir is a Gastroenterologist practicing medicine in Saint Louis, Missouri. Dr. Kushnir is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Bile Duct Obstruction, Choledocholithiasis, Endoscopy, and Colonoscopy.

Expertise in
8
conditions
Dr. Parakkal Deepak
Gastroenterology
Expertise in
8
conditions
Dr. Parakkal Deepak
Gastroenterology
Referral may be required

Washington University

660 S Euclid Ave, 
Saint Louis, MO 
 (0.1 miles away)
314-747-2075
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Parakkal Deepak is a Gastroenterologist practicing medicine in Saint Louis, Missouri. Dr. Deepak is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Colitis, Ileostomy, and Endoscopy.

Frequently Asked Questions about Dr. Matthew Ciorba

How do I make an appointment with Dr. Matthew Ciorba?

You can book an appointment with Dr. Matthew Ciorba by calling their office at 314-747-2066. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Matthew Ciorba a top-rated expert for Viral Gastroenteritis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew Ciorba is classified as an Elite expert for Viral Gastroenteritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Matthew Ciorba specialize in?

While Dr. Matthew Ciorba is a Gastroenterology, they have specific expertise in Viral Gastroenteritis, Crohn's Disease, and Colitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Matthew Ciorba participate in research or clinical trials?

Yes. Dr. Matthew Ciorba has published 129 articles and abstracts on conditions like Viral Gastroenteritis. You can view a list of Dr. Matthew Ciorba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Matthew Ciorba accept my insurance?

Dr. Matthew Ciorba accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-747-2066 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ciorba's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile